Literature DB >> 2697546

Oligodendrocyte progenitors isolated directly from developing telencephalon at a specific phenotypic stage: myelinogenic potential in a defined environment.

A L Gard1, S E Pfeiffer.   

Abstract

Oligodendroglia differentiate asynchronously in the developing central nervous system, passing through a series of stages identified by the sequential expression of specific differentiation antigens, culminating in the formation of the myelin sheath. In the work presented here, oligodendrocyte progenitors at a temporally narrow and well-defined phenotypic stage of development have been isolated in high purity and yield directly from postnatal rat telencephalon. This stage is identified by the expression of the O4 antigen, the earliest recognized surface marker specific for the oligodendroglial lineage, but the absence of the differentiation marker galactosylcerebroside (GalC). These O4+ GalC- progenitors first appear at birth (10(5)/telencephalon), 2-3 days before O4+ GalC+ oligodendrocytes. The work presented here demonstrates that a major subpopulation of O4+ GalC- progenitors (80%), which we have termed 'proligodendrocytes', is fully committed to terminal oligodendrocyte differentiation. A relatively small, maximal set of nutritional supplements are sufficient for proligodendrocytes to carry out the myelinogenic cascade of differentiated gene expression in a temporally normal manner, in quantitatively significant amounts, in normal ratios of myelin protein isoforms, and in a regulated relationship to the inclusion of myelin-specific products into myelin-like membrane sheets. An important corollary is that this step of myelinogenesis does not require contact with other cell types, in particular neurones and astrocytes, nor does it require unknown growth factors unique to these cell types. Additionally under these conditions, there exists a developmentally quiescent subpopulation (20%) of O4+ GalC- cells that may have significance for understanding the progenitors previously described in adult brain and suggested to be instrumental in remyelination under pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2697546     DOI: 10.1242/dev.106.1.119

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  41 in total

1.  In brain, Axl recruits Grb2 and the p85 regulatory subunit of PI3 kinase; in vitro mutagenesis defines the requisite binding sites for downstream Akt activation.

Authors:  Jason G Weinger; Pouyan Gohari; Ying Yan; Jonathan M Backer; Brian Varnum; Bridget Shafit-Zagardo
Journal:  J Neurochem       Date:  2008-07-01       Impact factor: 5.372

Review 2.  Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease.

Authors:  Je-Seong Won; Avtar K Singh; Inderjit Singh
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  A role for the acetylcholine receptor-inducing protein ARIA in oligodendrocyte development.

Authors:  T Vartanian; G Corfas; Y Li; G D Fischbach; K Stefansson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

Review 4.  Do oligodendrocytes divide?

Authors:  W T Norton
Journal:  Neurochem Res       Date:  1996-04       Impact factor: 3.996

5.  Transient transfection of oligodendrocyte progenitors by electroporation.

Authors:  W H Krueger; D L Madison; S E Pfeiffer
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

6.  Characterization of delayed rectifier Kv channels in oligodendrocytes and progenitor cells.

Authors:  B Attali; N Wang; A Kolot; A Sobko; V Cherepanov; B Soliven
Journal:  J Neurosci       Date:  1997-11-01       Impact factor: 6.167

7.  Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex.

Authors:  Delia M Talos; Rachel E Fishman; Hyunkyung Park; Rebecca D Folkerth; Pamela L Follett; Joseph J Volpe; Frances E Jensen
Journal:  J Comp Neurol       Date:  2006-07-01       Impact factor: 3.215

8.  Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development.

Authors:  Barbara S Mallon; H Elizabeth Shick; Grahame J Kidd; Wendy B Macklin
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

9.  Reversible inhibition of oligodendrocyte progenitor differentiation by a monoclonal antibody against surface galactolipids.

Authors:  R Bansal; S E Pfeiffer
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

10.  Phosphodiesterase-Ialpha/autotaxin's MORFO domain regulates oligodendroglial process network formation and focal adhesion organization.

Authors:  Jameel Dennis; Michael A White; Audrey D Forrest; Larra M Yuelling; Luciana Nogaroli; Fatemah S Afshari; Michael A Fox; Babette Fuss
Journal:  Mol Cell Neurosci       Date:  2007-11-12       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.